This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yim, S.F. Articles by Haines, C.J. Search for Related Content PubMed PubMed Citation Articles by Yim, S.F. Articles by Haines, C.J. Pubmed/NCBI databases Medline Plus Health Information Hormone Replacement Therapy

(Circulation. 1998;98:1631-1635.)
© 1998 American Heart Association, Inc.

Clinical Investigation and Reports

Prospective Randomized Study of the Effect of "Add-Back" Hormone Replacement on Vascular Function During Treatment With Gonadotropin-Releasing Hormone Agonists

S.F. Yim, MRCOG; T.K. Lau, MRCOG; D.S. Sahota, PhD; T.K.H. Chung, FRACOG; A.M.Z. Chang, FRACOG; ; C.J. Haines, FRACOG

From the Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.

Correspondence to Prof Christopher J. Haines, Department of Obstetrics and Gynaecology, Prince of Wales Hospital, Shatin, New Territories, Hong Kong. E-mail cjohnhaines{at}cuhk.edu.hk

Background—Gonadotropin-releasing hormone agonists (GnRHas) are a group of drugs that with long-term use induce a pseudomenopausal state in which estrogen production is suppressed. They are commonly used in the treatment of sex steroid–dependent conditions. "Add-back" hormone replacement therapy is used to prevent menopause-like symptoms and bone loss during GnRHa treatment, but it is also recognized that hypoestrogenism adversely affects vascular function. The aim of this study was to examine the effect of GnRHa and add-back therapy on vascular reactivity. This model serves as a paradigm for the effect of hormone replacement therapy in postmenopausal women.

Methods and Results—Measurements of endothelium-dependent and endothelium-independent vascular reactivity were compared in 2 groups of women treated with a GnRHa for 6 months. One group received estrogen/progestogen add-back therapy during the second 3 months of GnRHa treatment. Vascular reactivity was examined by use of ultrasound measurements of changes in brachial artery diameter. Endothelium-dependent changes were assessed during reactive hyperemia, whereas endothelium-independent changes were measured after the administration of glyceryl trinitrate sublingual spray. Treatment with the GnRHa alone had an inhibitory effect on endothelium-dependent relaxation. However, endothelium-dependent relaxation significantly improved in the group receiving add-back therapy (14.6%) compared with the group treated with GnRHa alone (8.6%) (P<0.01). There were no significant endothelium-independent changes in either group.

Conclusions—These results suggest that the administration of add-back therapy has a protective effect on vascular function in GnRHa-induced hypoestrogenism. As a model for the menopause, these results also suggest that the long-term administration of hormone replacement therapy would result in endothelium-dependent arterial relaxation, an observation previously attributed only to the acute administration of estrogen.

Key Words: hormones • vasculature

This article has been cited by other articles:

				G. Mercuro, F. Saiu, M. Deidda, S. Mercuro, C. Vitale, and G. M. C. Rosano Effect of Hormone Therapy on Exercise Capacity in Early Postmenopausal Women Obstet. Gynecol., October 1, 2007; 110(4): 780 - 787. [Abstract] [Full Text] [PDF]

				P. Collins, M. Flather, B. Lees, R. Mister, A. J. Proudler, J. C. Stevenson, and on behalf of the WHISP (Women's Hormone Interventi Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study Eur. Heart J., September 1, 2006; 27(17): 2046 - 2053. [Abstract] [Full Text] [PDF]

				H. Jokela, P. Dastidar, R. Rontu, A. Salomaki, K. Teisala, T. Lehtimaki, and R. Punnonen Effects of Long-Term Estrogen Replacement Therapy Versus Combined Hormone Replacement Therapy on Nitric Oxide-Dependent Vasomotor Function J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4348 - 4354. [Abstract] [Full Text] [PDF]

				M. B. Sorensen, P. Collins, P. J.L. Ong, C. M. Webb, C. S. Hayward, E. A. Asbury, P. D. Gatehouse, A. G. Elkington, G. Z. Yang, A. Kubba, et al. Long-Term Use of Contraceptive Depot Medroxyprogesterone Acetate in Young Women Impairs Arterial Endothelial Function Assessed by Cardiovascular Magnetic Resonance Circulation, September 24, 2002; 106(13): 1646 - 1651. [Abstract] [Full Text] [PDF]

				E. S. Surrey and M. D. Hornstein Prolonged GnRH Agonist and Add-Back Therapy for Symptomatic Endometriosis: Long-term Follow-up Obstet. Gynecol., May 1, 2002; 99(5): 709 - 719. [Abstract] [Full Text] [PDF]

				K. J. Mather, E. G. Norman, J. C. Prior, and T. G. Elliott Preserved Forearm Endothelial Responses with Acute Exposure to Progesterone: A Randomized Cross-Over Trial of 17-{beta} Estradiol, Progesterone, and 17-{beta} Estradiol with Progesterone in Healthy Menopausal Women J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4644 - 4649. [Abstract] [Full Text]